Advanced search

Report side effect

Report a suspected side effect or falsified product to the MHRA Yellow Card scheme.
Go to {yellow_card_logo} site
{arrow_up} Back to top

Scheriproct Suppositories

Active Ingredient:
prednisolone hexanoate, cinchocaine hydrochloride
Company:  
Karo Pharma AB See contact details
About Medicine
{medical_services}
Prescription only medicine
Healthcare Professionals (SmPC) Patient Leaflet (PIL) Product Information HCP Med Info
{arrow_left}
{arrow_right}
Product Information – Scheriproct Suppositories change of ownership

Please note that following a Change of Ownership, Karo Pharma are now Marketing Authorisation Holder for Scheriproct Suppositories.

For a period of time you may still receive packs of Scheriproct Suppositories in LEO Laboratories Limited packaging, displaying a LEO Laboratories Limited Marketing Authorisation number.

Please contact Karo Pharma for any queries related to this product.

Email: [email protected]
Tel: 0-808-189-4327
Karo Pharma AB
Company image
Address
Klara Norra Kyrkogata 33, Stockholm, Sweden
WWW
https://www.karopharma.com/
Telephone
+44 (0) 8000461977
Medical Information Direct Line
+44 (0) 8000461977
Medical Information e-mail
[email protected]
Customer Care direct line
+44 (0) 8000461977
Stock Availability
[email protected]